Explore more publications!
Virginia Healthcare Press
Got News to Share?

Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia Healthcare Press.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on January 16, 2026

Proactive MD Expands Access to Allergy Treatment with New Acquisitions
Jan. 16, 2026

Proactive MD Expands Access to Allergy Treatment with New Acquisitions

Indeterminate EIN Presswire
Paragon Home Care Provides Guidance on Choosing a Home Care Agency in McLean, VA
Jan. 16, 2026

Paragon Home Care Provides Guidance on Choosing a Home Care Agency in McLean, VA

Indeterminate EIN Presswire
Paragon Home Care Outlines Alzheimer’s and Dementia Care Services Available in McLean, VA
Jan. 16, 2026

Paragon Home Care Outlines Alzheimer’s and Dementia Care Services Available in McLean, VA

Indeterminate EIN Presswire
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Jan. 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Indeterminate GlobeNewswire
DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025
Jan. 16, 2026

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Jan. 16, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
Jan. 16, 2026

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters
Jan. 16, 2026

Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters

Indeterminate GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan. 16, 2026

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Jan. 16, 2026

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
Jan. 16, 2026

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

Indeterminate GlobeNewswire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
Jan. 16, 2026

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

Indeterminate GlobeNewswire
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jan. 16, 2026

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Indeterminate GlobeNewswire
MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
Jan. 16, 2026

MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

Indeterminate GlobeNewswire
AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead
Jan. 16, 2026

AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions